CYP 3A4 - inhibitoren erythromycin påvirker ikke risperidons farmakokinetik eller den aktive antipsykotiske fraktion.
The CHMP was also of the opinion that doses of risperidone > 8 mg/ day should not be routinely used and should be restricted to certain group of patients.